BIOMERIEUX/ FR0013280286 /
2024-04-26 9:05:12 AM | Chg. 0.00 | Volume | Bid5:29:21 PM | Ask5:29:21 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
100.10EUR | 0.00% | 0 Turnover: - |
-Bid Size: - | -Ask Size: - | 12.01 bill.EUR | 0.84% | 33.50 |
GlobeNewswire
04-18
deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing...
GlobeNewswire
2023-12-04
Oxford Biomedica signs agreement to acquire ABL Europe from Institut Mérieux, consolidating position...
GlobeNewswire
2023-09-20
Oxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect to the proposed...
GlobeNewswire
2021-10-04
Quotient Limited Announces Appointment of New Chief Scientific & Medical Officer
GlobeNewswire
2021-09-16
Inventiva announces major recruitments to accelerate the development of lanifibranor in NASH
GlobeNewswire
2021-06-01
Quotient Limited Provides Fourth Quarter and Full Year Fiscal 2021 Results and provides Business Upd...
GlobeNewswire
2021-03-10
Oncorus Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
GlobeNewswire
2021-01-04
Oncorus to Build GMP Viral Immunotherapy Clinical Manufacturing Facility in Andover, Mass.
GlobeNewswire
2020-12-07
Oncorus Appoints Steve Harbin as Chief Operating Officer and Chief of Staff
GlobeNewswire
2020-09-17
Victory Square Provides Corporate Update on the Strong Performance of Portfolio Companies
GlobeNewswire
2020-05-04
Alexis RIDEAU appointed Chief Executive Officer of DEINOVE with the ambition to strengthen the Comp...
GlobeNewswire
2020-04-01
Cancer Biomarker Sales to Reach US$ 27 Bn by 2025; Government Funding Pivotal in Accelerating Market...
GlobeNewswire
2020-03-18
Commercial launch of BIOME Oléoactif®, new cosmetic active co-developed by Deinove and Hallstar Fran...
GlobeNewswire
2020-03-11
DEINOVE passes the 2nd milestone of the AGIR program and receives €1.5m from Bpifrance